摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methyl-2,3,5,6-tetrahydro-7(1H)-indolizinone | 141346-16-9

中文名称
——
中文别名
——
英文名称
3-Methyl-2,3,5,6-tetrahydro-7(1H)-indolizinone
英文别名
3-methyl-2,3,5,6-tetrahydro-1H-indolizin-7-one
3-Methyl-2,3,5,6-tetrahydro-7(1H)-indolizinone化学式
CAS
141346-16-9
化学式
C9H13NO
mdl
——
分子量
151.208
InChiKey
UEUHCIQTMGBNHB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-Methyl-2,3,5,6-tetrahydro-7(1H)-indolizinone 氢气硼酸三乙胺 作用下, 以 乙醚乙醇乙酸乙酯 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 5.0h, 生成 ((Z)-4-Hydroxy-7-methyl-3-phenyl-7,8,9,10-tetrahydro-6H-1-oxa-2,8-diaza-cyclopentacyclononen-5-yl)-phenyl-methanone
    参考文献:
    名称:
    Occhiato, Ernesto G.; Guarna, Antonio; Sarlo, Francesco de, Gazzetta Chimica Italiana, 1993, vol. 123, # 8, p. 425 - 430
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    N-Bridgehead polycyclic compounds by sequential rearrangement-annulation of isoxazoline-5-spirocyclopropanes. 6. A general synthetic method for 5,6-dihydro-7(8H)- and 2,3,5,6-tetrahydro-7(1H)-indolizinones
    摘要:
    The thermal rearrangement-annulation of isoxazoline-5-spirocyclopropanes 4a-e substituted with a chain bearing a carbonyl group affords, in one step, 5,6-dihydro-7(8H)-indolizinones 5a-e. The rearrangement-annulation of isoxazoline-5-spirocyclopropanes 4f-h substituted with a chlorine on the side chain affords, also in one step, 2,3,5,6-tetrahydro-7(1H)-indolizinones 5f-h. When the cyclopropane ring is fused to a cyclohexane, or when a cyclohexanone is present in the side chain of isoxazoline 4, the process leads to N-bridgehead tricyclic compounds. Short rection times, mild reaction conditions, complete regioselectivity, and good stereoselectivity are the valuable features of this strategy.
    DOI:
    10.1021/jo00041a027
点击查看最新优质反应信息

文献信息

  • Enantioselective synthesis of indolizine derivatives by rearrangement-cyclization of isoxazoline-5-spirocyclopropanes
    作者:Ernesto G. Occhiato、Antonio Guarna、Laura Michela Spinetti
    DOI:10.1016/s0040-4020(01)81553-2
    日期:1993.1
    (3S,7S,8aS)-3-Methyl-7-hydroxyoctahydroindolizine (13) was prepared with an enantiomeric excess of 74%. in five steps starting from enantiomerically pure (S)-(+)-5-nitro-2-pentanol (5). (3S,5S,7S,8aS)-(-)-3-Methyl-5-phenyl-7-hydroxyoctahydroindolizine (15) and (3S,5R,7R,8aR)-(+)-3-methyl-5-phenyl-7-hydroxyoctahydroindolizine (16) were also obtained starting from (5) with an ee of 96%. The synthetic strategy required the enantioselective enzymatic reduction of 5-nitro-2-pentanone (4) to 5 (> 99% ee) and its conversion to (R)-(-)-2-chloro-5-nitropentane (7) (> 90% ee). Cycloadditions of the corresponding nitrile oxide prepared in situ from 7 with methylenecyclopropane (8) or 1-methylene-2-phenylcyclopropane (9) produced chiral isoxazolines 1 and 2, which were converted by thermolysis to 2,3,5,6-tetrahydro-3-methylindolizin-7(1H)-one (10), and 2,3,5,6-tetrahydro-3-methyl-5-phenylindolizin-7(1H)-ones (11) and (12) respectively. The enantioselectivity of the thermal rearrangement is dependent on the experimental conditions and on the structures of the chiral isoxazolines. Catalytic hydrogenation of the indolizinones 10, 11 and 12, afforded the substituted hydroxyoctahydroindolizines 13, 15 and 16 with high stereoselective control of all stereogenic centers.
    (3S,7S,8aS)-3-甲基-7-羟基八氢吲哚嗪(13)以(3S,7S,8aS)-3-甲基-7-羟基八氢吲哚嗪的形式制备,其对映体过量为74%,从旋光纯的(S)-(+)-5-硝基-2-戊醇(5)开始,通过五步反应合成。同样地,从(5)开始,还获得了(3S,5S,7S,8aS)-(-)-3-甲基-5-苯基-7-羟基八氢吲哚嗪(15)和(3S,5R,7R,8aR)-(+)-3-甲基-5-苯基-7-羟基八氢吲哚嗪(16),其ee为96%。合成策略需要5-硝基-2-戊酮(4)通过酶促不对称还原生成(5)(> 99% ee),随后将其转化为(R)-(-)-2-氯-5-硝基戊烷(7)(> 90% ee)。将7原位制备的腈亚胺与甲基环丙烷(8)或1-甲基-2-苯基环丙烷(9)进行环加成,产生手性异恶唑烷1和2,随后通过热裂解分别转化为2,3,5,6-四氢-3-甲基吲哚嗪-7(1H)-酮(10)、2,3,5,6-四氢-3-甲基-5-苯基吲哚嗪-7(1H)-酮(11)和(12)。热重排的对映选择性取决于实验条件和手性异恶唑烷的结构。催化氢化吲哚嗪酮10、11和12,得到取代的羟基八氢吲哚嗪13、15和16,对所有手性中心均具有高度的立体选择性控制。
  • N-Bridgehead polycyclic compounds by sequential rearrangement-annulation of isoxazoline-5-spirocyclopropanes. 6. A general synthetic method for 5,6-dihydro-7(8H)- and 2,3,5,6-tetrahydro-7(1H)-indolizinones
    作者:Ernesto G. Occhiato、Antonio Guarna、Alberto Brandi、Andrea Goti、Francesco De Sarlo
    DOI:10.1021/jo00041a027
    日期:1992.7
    The thermal rearrangement-annulation of isoxazoline-5-spirocyclopropanes 4a-e substituted with a chain bearing a carbonyl group affords, in one step, 5,6-dihydro-7(8H)-indolizinones 5a-e. The rearrangement-annulation of isoxazoline-5-spirocyclopropanes 4f-h substituted with a chlorine on the side chain affords, also in one step, 2,3,5,6-tetrahydro-7(1H)-indolizinones 5f-h. When the cyclopropane ring is fused to a cyclohexane, or when a cyclohexanone is present in the side chain of isoxazoline 4, the process leads to N-bridgehead tricyclic compounds. Short rection times, mild reaction conditions, complete regioselectivity, and good stereoselectivity are the valuable features of this strategy.
  • Occhiato, Ernesto G.; Guarna, Antonio; Sarlo, Francesco de, Gazzetta Chimica Italiana, 1993, vol. 123, # 8, p. 425 - 430
    作者:Occhiato, Ernesto G.、Guarna, Antonio、Sarlo, Francesco de、Brandi, Alberto、Goti, Andrea、et al.
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-